ACAD ACADIA Pharmaceuticals Inc. Stock Quote

ACAD [NASD]

Index	-	P/E	-	EPS (ttm)	-1.64	Insider Own	0.20%	Shs Outstand	160.42M	Perf Week	1.15%
Market Cap	2.88B	Forward P/E	-	EPS next Y	-0.94	Insider Trans	-4.15%	Shs Float	160.07M	Perf Month	5.39%
Income	-261.70M	PEG	-	EPS next Q	-0.26	Inst Own	94.20%	Short Float	4.44%	Perf Quarter	-27.45%
Sales	463.40M	P/S	6.21	EPS this Y	-12.00%	Inst Trans	-0.17%	Short Ratio	5.29	Perf Half Y	-15.38%
Book/sh	3.52	P/B	5.00	EPS next Y	22.50%	ROA	-34.20%	Target Price	25.00	Perf Year	-58.70%
Cash/sh	3.41	P/C	5.17	EPS next 5Y	25.00%	ROE	-43.10%	52W Range	15.68 - 57.46	Perf YTD	-67.08%
Dividend	-	P/FCF	-	EPS past 5Y	-1.80%	ROI	-45.80%	52W High	-69.37%	Beta	0.60
Dividend %	-	Quick Ratio	6.70	Sales past 5Y	491.50%	Gross Margin	95.70%	52W Low	12.25%	ATR	0.70
Employees	610	Current Ratio	6.80	Sales Q/Q	4.60%	Oper. Margin	-56.90%	RSI (14)	54.11	Volatility	4.84% 4.21%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-1.60%	Profit Margin	-56.50%	Rel Volume	1.10	Prev Close	17.51
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 04 AMC	Payout	-	Avg Volume	1.34M	Price	17.60
Recom	2.70	SMA20	2.45%	SMA50	2.90%	SMA200	-36.97%	Volume	1,476,908	Change	0.51%

Oct-14-21

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$20

Sep-23-21

Resumed

Needham

Hold

Jun-10-21

Initiated

Berenberg

Hold

$29

Apr-07-21

Downgrade

H.C. Wainwright

Buy → Neutral

$43 → $18

Apr-06-21

Downgrade

Mizuho

Buy → Neutral

$37 → $25

Apr-06-21

Downgrade

Jefferies

Buy → Hold

$40 → $21

Apr-06-21

Downgrade

Goldman

Buy → Neutral

$73 → $25

Apr-06-21

Downgrade

Canaccord Genuity

Buy → Hold

$40 → $26

Apr-05-21

Downgrade

Raymond James

Outperform → Mkt Perform

Mar-10-21

Downgrade

BofA Securities

Buy → Neutral

Mar-09-21

Reiterated

H.C. Wainwright

Buy

$60 → $43

Mar-09-21

Downgrade

Stifel

Buy → Hold

$68 → $27

Mar-09-21

Downgrade

Raymond James

Strong Buy → Outperform

$65 → $35

Mar-09-21

Downgrade

Guggenheim

Buy → Neutral

Mar-09-21

Downgrade

Citigroup

Buy → Neutral

$66 → $35

Dec-16-20

Initiated

Mizuho

Buy

$69

Nov-16-20

Upgrade

Raymond James

Outperform → Strong Buy

$65

Aug-25-20

Initiated

Raymond James

Outperform

$65

Aug-20-20

Initiated

Morgan Stanley

Overweight

$55

Jul-07-20

Upgrade

Stifel

Hold → Buy

$41 → $71

Oct-15-21 08:25AM	Analysts are Cutting Price Targets of These 10 Stocks Insider Monkey
Sep-03-21 11:31AM	Acadia (ACAD) Down 10.8% Since Last Earnings Report: Can It Rebound? Zacks
Sep-02-21 09:00AM	Acadia Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire
Sep-01-21 04:05PM	Acadia Pharmaceuticals Announces Executive Leadership Change Business Wire
Aug-26-21 09:55AM	Stanley Druckenmiller is Loading Up on These 15 Stocks Insider Monkey
Aug-22-21 08:04AM	ACADIA Pharmaceuticals (NASDAQ:ACAD shareholders incur further losses as stock declines 5.1% this week, taking one-year losses to 56% Simply Wall St.
Aug-06-21 04:31PM	Acadia Pharmaceuticals Inc (ACAD) Q2 2021 Earnings Call Transcript Motley Fool
01:54PM	Lifshitz Law Firm, P.C. Announces Investigations of 3D Systems Corp. (NYSE: DDD), Acadia Pharmaceuticals, Inc. (NasdaqGS: ACAD), ChemoCentryx, Inc. (NasdaqGS: CCXI), and Peloton Interactive, Inc (NasdaqGS: PTON) GlobeNewswire
Aug-05-21 04:05PM	Acadia Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021 Business Wire -8.55%
12:53PM	ACADIA (ACAD) Q2 Earnings Beat, Revenues Miss Estimates Zacks
Aug-04-21 05:25PM	Acadia Pharmaceuticals (ACAD) Reports Q2 Loss, Misses Revenue Estimates Zacks
Aug-03-21 07:30PM	ACADIA: The Streets Gaze Turns to FDA Meetings Outcome on DRP Treatment TipRanks
Jul-28-21 03:03PM	Analysts Estimate Acadia Pharmaceuticals (ACAD) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-21-21 05:05PM	The New England Journal of Medicine Publishes Results from the Phase 3 HARMONY Study Evaluating Pimavanserin in Patients with Dementia-Related Psychosis Business Wire
09:00AM	Acadia Pharmaceuticals to Announce Second Quarter 2021 Financial Results on August 4, 2021 Business Wire
Jul-16-21 11:22AM	Synlogic's (SYBX) Begins Phase I Study for PKU Treatment Zacks
Jul-14-21 09:00AM	Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the Alzheimers Association International Conference 2021 (AAIC) Business Wire
Jul-06-21 11:37AM	Hedge Funds Arent Crazy About ACADIA Pharmaceuticals Inc. (ACAD) Anymore Insider Monkey
Jun-21-21 05:02PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 21, 2021 - ACAD Newsfile
03:33PM	Today - Final Deadline for Investors With Losses Exceeding $100K to Actively Participate in ACADIA Pharmaceuticals Inc. (ACAD) Class Action: Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
09:45AM	Lawsuits Filed Against ACAD, EBS and WISH - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
09:09AM	DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
05:40AM	CLASS ACTION UPDATE for ACAD, PRVB and OCGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
01:00AM	FINAL DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Jun-20-21 12:20PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline ACAD GlobeNewswire
11:35AM	SHAREHOLDER ALERT: ACAD SKLZ WPG: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
11:10AM	SHAREHOLDER ALERT: ACAD EBS SKLZ: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Jun-19-21 04:06PM	ACAD INVESTOR DEADLINE MONDAY: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Now Newsfile
08:26AM	MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Jun-18-21 08:20PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, EBS and FREQ ACCESSWIRE
06:30PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline ACAD ACCESSWIRE
02:32PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - ACAD Newsfile
01:05PM	FINAL DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:00PM	SHAREHOLDER ALERT: ACAD CCIV WPG: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:57AM	DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
10:00AM	Final Deadline for Investors to Actively Participate in ACADIA Pharmaceuticals Inc. (ACAD) Class Action: Bronstein, Gewirtz & Grossman, LLC Newsfile
Jun-17-21 11:41AM	ACAD LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Acadia Pharmaceuticals Inc. Newsfile
11:00AM	Tomorrow Deadline for Investors to Actively Participate in ACADIA Pharmaceuticals Inc. (ACAD) Class Action: Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
10:56AM	DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
09:36AM	ACAD SHAREHOLDER DEADLINE TOMORROW: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Now GlobeNewswire
06:08AM	ACAD ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 18, 2021 in the Class Action Filed on Behalf of Acadia Pharmaceuticals Inc. Limited Shareholders Newsfile
01:00AM	JUNE 18 DEADLINE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Jun-16-21 10:00PM	DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Acadia Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Business Wire
03:20PM	Lawsuits Filed Against ACAD, CCXI and DNMR - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
02:30PM	2-Day Deadline Alert: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
02:10PM	ACAD 2-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Now ACCESSWIRE
01:10PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - ACAD Newsfile
11:40AM	The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acadia Pharmaceuticals Inc. (ACAD) Business Wire
11:15AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ACAD, ARRY and FREQ ACCESSWIRE
11:00AM	Two Days Left to Actively Participate in ACADIA Pharmaceuticals Inc. (ACAD) Class Action: Bronstein, Gewirtz & Grossman, LLC Business Wire
10:55AM	FRIDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Jun-15-21 02:15PM	LAWSUITS FILED AGAINST ACAD, PTON and UI - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
12:43PM	Acadia Pharmaceuticals, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm GlobeNewswire
12:05PM	ACAD 3-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Now Newsfile
12:00PM	3-Day Deadline Alert: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:45AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ACAD, PRVB and FREQ ACCESSWIRE
11:15AM	DEADLINE ALERT for FUV, ACAD, and CCIV: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:54AM	FRIDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
10:30AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CS, ACAD and SKLZ ACCESSWIRE
10:00AM	Last Few Days to Actively Participate in ACADIA Pharmaceuticals Inc. (ACAD) Class Action: Bronstein, Gewirtz & Grossman, LLC Newsfile
Jun-14-21 09:00PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, EBS and PRVB ACCESSWIRE
07:23PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline ACAD GlobeNewswire
06:28PM	ACAD ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 18, 2021 in the Class Action Filed on Behalf of Acadia Pharmaceuticals Inc. Limited Shareholders Newsfile
05:00PM	ACAD 4-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Now Before June 18th Application Deadline ACCESSWIRE
02:30PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - ACAD Newsfile
01:00PM	JUNE 18 DEADLINE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:30AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ACAD, WISH and SPCE ACCESSWIRE
11:00AM	DEADLINE ALERT for ACAD, CCIV, PINS, VWAGY: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:30AM	FRIDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
10:00AM	FUV, ACAD & EBS Few Days Left to Actively Participate in Class Actions: Bronstein, Gewirtz & Grossman LLC GlobeNewswire
09:35AM	LAWSUITS FILED AGAINST ACAD, EBS and SKLZ - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
09:00AM	Acadia Pharmaceuticals, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm GlobeNewswire
05:40AM	CLASS ACTION UPDATE for ACAD, PTON and PCT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Jun-13-21 01:15PM	ACAD 5-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Before June 18th Application Deadline in Securities Class Action Newsfile
10:15AM	CLASS ACTION UPDATE for ACAD, EBS and ATER: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Jun-12-21 06:09PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD Newsfile
03:40PM	ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Acadia Pharmaceuticals Inc. Investors with LARGE LOSSES to Secure Counsel Before Important June 18 Deadline in Securities Class Action ACAD ACCESSWIRE
11:16AM	ACAD 6-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm, Deadline Approaching in Securities Class Action GlobeNewswire
Jun-11-21 11:00PM	DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Acadia Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Business Wire
05:25PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, EBS and DNMR ACCESSWIRE
04:45PM	FINAL DEADLINE IMMINENT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:00PM	SHAREHOLDER ALERT: ACAD EBS PCT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
11:47AM	ACAD BREAKING ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Acadia Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 18 Deadline in Securities Class Action ACAD Business Wire
11:45AM	CLASS ACTION UPDATE for ACAD, EBS and SPCE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:00AM	FUV, ACAD & EBS Approaching Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Lead Plaintiff Deadlines: June 18, 2021 ACCESSWIRE
10:36AM	SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
09:46AM	ACAD 7-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Now, June 18th Application Deadline Approaching ACCESSWIRE
Jun-10-21 11:59PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD PR Newswire
12:30PM	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acadia Pharmaceuticals Inc. (ACAD) GlobeNewswire
12:05PM	ACAD 8-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Newsfile
11:00AM	FUV, ACAD & EBS Last Few Days to Actively Participate: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Lead Plaintiff Deadlines: June 18, 2021 ACCESSWIRE
10:35AM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Jun-09-21 02:55PM	LAWSUITS FILED AGAINST CAN, ACAD and PCT - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
02:15PM	FINAL DEADLINE APPROACHING: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:00AM	SHAREHOLDER ALERT: ACAD UI SPCE: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:33AM	UPCOMING DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
10:00AM	FUV, ACAD & EBS Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Lead Plaintiff Deadlines: June 18, 2021 GlobeNewswire
09:35AM	ACAD 9-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Now ACCESSWIRE
Jun-08-21 08:00PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - ACAD Newsfile
06:32PM	ACAD 10-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Now Newsfile

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; Trofinetide, a novel synthetic analog for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor for treating cognition and schizophrenia. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ridloff Elena	EVP and CFO	Apr 30	Sale	20.33	1,032	20,981	10,553	Apr 30 06:55 PM
KIM AUSTIN D.	EVP & General Counsel	Apr 30	Sale	20.33	1,054	21,428	11,371	Apr 30 06:54 PM
Stankovic Srdjan R.	President	Apr 30	Sale	20.33	4,230	85,996	36,434	Apr 30 06:53 PM
DAVIS STEPHEN	CEO	Apr 30	Sale	20.33	7,850	159,590	49,312	Apr 30 06:52 PM
KIM AUSTIN D.	EVP & General Counsel	Feb 04	Sale	50.61	2,107	106,635	9,911	Feb 08 09:00 PM
Stankovic Srdjan R.	President	Feb 04	Sale	50.61	8,429	426,592	31,049	Feb 08 09:00 PM
DAVIS STEPHEN	CEO	Feb 04	Sale	50.61	14,195	718,409	28,900	Feb 08 09:00 PM
Ridloff Elena	EVP and CFO	Feb 04	Sale	50.61	2,051	103,801	8,340	Feb 08 09:00 PM
Stankovic Srdjan R.	President	Jan 12	Option Exercise	18.12	700	12,684	20,947	Jan 14 07:03 PM
Stankovic Srdjan R.	President	Jan 12	Sale	55.01	700	38,507	20,247	Jan 14 07:03 PM
Stankovic Srdjan R.	President	Jan 08	Option Exercise	27.44	29,733	815,988	49,980	Jan 08 07:28 PM
Stankovic Srdjan R.	President	Jan 08	Sale	55.22	29,733	1,641,832	20,247	Jan 08 07:28 PM
Stankovic Srdjan R.	President	Jan 07	Option Exercise	35.80	61,619	2,205,960	81,866	Jan 08 07:28 PM
Stankovic Srdjan R.	President	Jan 07	Sale	55.12	61,619	3,396,187	20,247	Jan 08 07:28 PM
YANG MICHAEL J.	EVP and CCO	Jan 06	Sale	53.34	1,120	59,741	8,059	Jan 08 07:31 PM
KIM AUSTIN D.	EVP & General Counsel	Jan 06	Sale	53.34	678	36,165	5,518	Jan 08 07:30 PM
Ridloff Elena	EVP and CFO	Jan 06	Sale	53.34	1,016	54,193	3,901	Jan 08 07:29 PM
Stankovic Srdjan R.	President	Jan 06	Sale	53.34	1,725	92,012	20,247	Jan 08 07:28 PM
DAVIS STEPHEN	CEO	Jan 06	Sale	53.34	3,484	185,837	24,482	Jan 08 07:28 PM
Stankovic Srdjan R.	President	Nov 20	Sale	53.50	2,728	145,948	16,528	Nov 20 09:29 PM
KIM AUSTIN D.	EVP & General Counsel	Oct 27	Option Exercise	17.58	8,750	153,825	12,601	Oct 29 04:12 PM
KIM AUSTIN D.	EVP & General Counsel	Oct 27	Sale	45.10	8,750	394,636	3,851	Oct 29 04:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience